Lakefront Biotherapeutics N.V.
Status: Publicly traded
Direct answer
Lakefront Biotherapeutics N.V. is publicly traded on NASDAQ under the ticker LKFT.
Galapagos NV is a biotechnology company that specializes in the discovery and advancement of novel small molecule and antibody-based therapeutics. Its active clinical development programs include drugs like filgotinib and GLP3667, alongside the Toledo program and therapies targeting idiopathic pulmonary fibrosis. The firm was established on June 30, 1999, by co-founders Onno van de Stolpe, Rudi Pauwels, and Helmuth...
Can you invest in Lakefront Biotherapeutics N.V.?
Yes. Lakefront Biotherapeutics N.V. trades publicly on NASDAQ as LKFT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lakefront Biotherapeutics N.V.
Detailed equity research is provided by MarketSnap.